SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001367644-24-000042
Filing Date
2024-03-15
Accepted
2024-03-15 17:16:03
Documents
1
Period of Report
2024-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1710537351.html 4  
1 FORM 4 wk-form4_1710537351.xml 4 3860
  Complete submission text file 0001367644-24-000042.txt   5289
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 400 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address
Fox Jennifer Lynne (Reporting) CIK: 0001914879 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 24755966